The diagnosis of interstitial lung disease (ILD) can be difficult, especially in the early stages when pulmonary function tests (PFTs) show only minor changes. To improve the effectiveness of early diagnosis, researchers wanted to evaluate the potential of artificial intelligence (AI)-based software to support pulmonary specialists in analyzing PFT results.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Heterogeneous safety profiles for dermatological and endocrine AEs
Not all GLP1-RA are the same
- Neuroendocrine tumors
Precision medicine in diagnostics and therapy
- Irritable Bowel Syndrome
Functional disorder of gut-brain interaction – a biopsychosocial concept
- GLP1 receptor agonists
Positive influence on substance use and addiction
- Sleep apnea and cardiovascular diseases
Breathless through the night
- Diagnostics, differentiation and multimodal therapy
Vulvar diseases and vulvodynia
- From symptom to diagnosis
Abdominal pain – Prostate lipoma
- Acute pulmonary embolism: new AHA/ACC guideline